Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Patients may experience this as generalized weakness, reduced exercise tolerance, or muscle discomfort, particularly during physical activity
Current Candidates for Tirzepatide Because tirzepatide is accessible right now, it is the primary consideration for: Individuals requiring immediate intervention for class II or class III obesity
Across the studies, the average duration of treatment was 39 weeks, followed by an average follow-up period of 32 weeks after participants stopped taking the drugs
The dataset is ideal for longitudinal cohorting analysis for studying long-term implications like concomitant therapy persistence and related drug use of new treatments like GLP-1
Always consult a healthcare professional if you experience side effects or need medical advice while using Mounjaro
2025;39:e153e154
US$ 28.95
US$ 28.64
US$ 27.88
US$ 21.92
US$ 20.41
